Liang Han

4.9k citations
88 papers · 3.9k indexed · 1 hit paper · h-index 33
Topics
Nanoparticle-Based Drug Delivery (19 papers)RNA Interference and Gene Delivery (15 papers)Nanoplatforms for cancer theranostics (15 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Liang Han

79 papers receiving 3.8k citations

Hit Papers

Advances of nanoparticles as drug delivery systems for di...20222026202320242022100200300

Peers

Liang Han
Comparison fields: 5 of 128
  • Molecular Biology 2.0k
  • Biomaterials 1.5k
  • Biomedical Engineering 1.1k
  • Materials Chemistry 397
  • Polymers and Plastics 387
Replace Jinning Lou with:
Jinning Lou China
Rongqin Huang China
Chen Jiang China
Hongliang Xin China
Meng Zheng China
Inge S. Zuhorn Netherlands
Chen Jiang China
Jiangbing Zhou United States
Tao Sun China
Changyou Zhan China
Liang Han relative to Jinning Lou China Jinning Lou's profile →
Citations per field
00.5×3.5×
Jinning Lou · 1×
Citations per year

Countries citing papers authored by Liang Han

Since Specialization
Citations

This map shows the geographic impact of Liang Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Han more than expected).

Fields of papers citing papers by Liang Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Han. The network helps show where Liang Han may publish in the future.

Co-authorship network of co-authors of Liang Han

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Han. A scholar is included among the top collaborators of Liang Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Han. Liang Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 5
4 0
5 2
6 0
7 2
8 11
9 3
10 10
11 6
12 5
13 63
14 256
15 27
16 17
17 90
18 214
19 80
20 59

About Liang Han

Liang Han is a scholar working on Biomaterials, Neurology and Physiology, having authored 88 papers that have together received 3.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (15 papers) and Nanoplatforms for cancer theranostics (15 papers). The work is most often cited by research in Biomaterials (1.5k citations), Pharmaceutical Science (306 citations) and Neurology (349 citations). Liang Han has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Rongqin Huang, Chen Jiang, Shuhuan Liu, Shixian Huang, Chen Jiang, Jianfeng Li, Kun Shao, Weilun Ke, Liya Ye and Jinning Lou. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026